$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/711
  • A61K-009/14
  • A61K-031/7088
  • A61P-003/10
  • A61P-037/06
  • C12N-015/113
  • A61K-009/00
  • A61K-009/16
  • A61K-009/19
  • C12N-015/11
출원번호 US-0822774 (2010-06-24)
등록번호 US-9115357 (2015-08-25)
발명자 / 주소
  • Brown, Larry R.
  • Bisker-Leib, Vered
  • Scott, Terrence L.
  • Lafreniere, Debra
  • Machen, Jennifer
  • Giannoukakis, Nick
출원인 / 주소
  • BAXTER INTERNATIONAL INC.
대리인 / 주소
    Marshall, Gerstein & Borun LLP
인용정보 피인용 횟수 : 0  인용 특허 : 90

초록

AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes

대표청구항

1. A composition comprising microspheres, said microspheres comprising (a) polyvinyl pyrrolidone and polyethylene glycol, (b) a polycation, and (c) thiolated oligonucleotides including a first antisense sequence that targets CD40 primary transcript, a second antisense sequence that targets CD80 prim

이 특허에 인용된 특허 (90)

  1. Bennett C. Frank ; Cowsert Lex M., Antisense modulation of CD40 expression.
  2. Shefer Adi ; McDermott Keith J. ; Shefer Shmuel David ; Tan Chee-Teck, Apparatus for preparing a solid phase microparticulate composition.
  3. Ramstack, J. Michael, Apparatus for preparing microparticles using liquid-liquid extraction.
  4. Neeb, Daniel A.; MontAlto, Thomas P., Apparatus for reducing the incidence of tampering with automatic fire sprinkler assemblies.
  5. Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Brookline MA) Langer Robert S. (Newton MA), Biodegradable injectable nanoparticles.
  6. Hubbell Jeffrey A.,CHX ; Kieras Mark T. ; Ron Eyal S. ; Rowe Stephen C., Biodegradable macromers for the controlled release of biologically active substances.
  7. Johnson OluFunmi Lily (Cambridge MA) Ganmukhi Medha M. (Wexford PA) Bernstein Howard (Cambridge MA) Auer Henry (Belmont MA) Khan M. Amin (Dowington PA), Composition for sustained release of human growth hormone.
  8. Roberts James M. ; Coats Steven R. ; Fero Matthew L., Compositions and methods for mediating cell cycle progression.
  9. Eljamal Mohammed ; Patton John S. ; Foster Linda ; Platz Robert M., Compositions and methods for nucleic acid delivery to the lung.
  10. Eljamal Mohammed ; Patton John S. ; Foster Linda ; Platz Robert M., Compositions and methods for nucleic acid delivery to the lung.
  11. Relton Julian Marcus,GBX, Concentrated antibody preparation.
  12. Thanoo Bagavathikanun Chithambara ; Murtagh James, Continuous microsphere process.
  13. Park Tae G. (Cambridge MA) Cohen Smadar (Petach-Tickva MA ILX) Langer Robert S. (Newton MA), Controlled drug delivery using polymer/pluronic blends.
  14. Chen Yan,AUX ; Gray Bruce Nathaniel,AUX, Controlled release preparations for cytotoxic or cytostatic drugs.
  15. Maniar Manoj (Baltimore MD) Domb Abraham J. (Baltimore MD), Controlled released microparticulate delivery system for proteins.
  16. Singh Maninder (Mountain Brook Rodeo CA) Nunberg Jack H. (Mountain Brook Oakland CA) Tice Thomas R. (Mountain Brook Birmingham AL) Hudson Michael E. (Mountain Brook Gardendale AL) Gilley Richard M. (, Controlled-release formulations of interleukin-2.
  17. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakls, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
  18. Illum Lisbeth (Charlottenlund DKX), Drug delivery system.
  19. Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL), Drug delivery system and method of making the same.
  20. Laakso, Timo; Reslow, Mats, Encapsulation method.
  21. Roy Krishnendu ; Mao Hai-Quan ; Truong Vu L. ; August Thomas ; Leong Kam W., Gene delivery system.
  22. Kim Sinil (Solana Beach CA), Heterovesicular liposomes.
  23. Van Nest,Gary; Tuck,Stephen, Immunomodulatory formulations and methods for use thereof.
  24. Tice Thomas R. (Birmingham AL) Lewis Danny H. (Gardendale AL) Cowsar Donald R. (Birmingham AL) Beck Lee R. (Birmingham AL), Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
  25. Cohen Smadar (Petach-Tickva ILX) Bano Carmen (Valencia PA ESX) Visscher Karyn B. (State College PA) Chow Marie (Brookline MA) Allcock Harry R. (State College PA) Langer Robert S. (Newton MA), Ionically cross-linked polymeric microcapsules.
  26. Woiszwillo, James E., Ionically formulated biomolecule microcarriers.
  27. Woiszwillo James E. (Milford MA), Macromolecular microparticles and methods of production.
  28. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D., Macromolecular microparticles and methods of production and use.
  29. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D. ; Riske Frank J., Macromolecular microparticles and methods of production and use.
  30. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D. ; Riske Frank J., Macromolecular microparticles and methods of production and use.
  31. Bagavathikanun Chithambara Thanoo ; James Murtagh, Method and apparatus for formulating microspheres and microcapsules.
  32. Thanoo Bagavathikanun Chithambara ; Murtagh James, Method and apparatus for formulating microspheres and microcapsules.
  33. Woiszwillo James E. (Milford MA) Rothstein Fred (Long Beach CA), Method for isolating biomolecules from a biological sample with linear polymers.
  34. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  35. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Method for producing microcapsule.
  36. Kobayashi Masao (Kyoto JPX) Nishioka Yukiko (Toyonaka JPX) Suzuki Takehiko (Toyono-gun JPX) Matsukawa Yashuhisa (Osaka JPX), Method for producing sustained release microsphere preparation.
  37. Tice Thomas R. (Birmingham AL) Dillon Deborah L. (Helena AL) Mason David W. (Birmingham AL) McRae-McFarlane Amanda (Vastra Frolunda SEX) Dahlstrom Annica B. (Askin SEX), Method for stimulating nerve fiber growth.
  38. Wilhelmus Everhardus Hennink NL; Okke Franssen NL, Method for the preparation of microspheres which contain colloidal systems.
  39. Jones David Hugh,GBX ; Farrar Graham Henry,GBX ; Clegg James Christopher Stephen,GBX, Method of making microencapsulated DNA for vaccination and gene therapy.
  40. Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL) Eldridge John H. (Birmingham AL) Staas Jay K. (Birmingham AL) Hollingshead Melinda G. (Birmingham AL) Shannon William M. (Birmingham A, Method of potentiating an immune response.
  41. Kamei Shigeru (Takarazuka JPX) Yamada Minoru (Kawanishi JPX) Ogawa Yasuaki (Ohyamazaki-cho JPX), Method of producing sustained-release microcapsules.
  42. Mark A. Tracy ; John D. Herberger ; Paul A. Burke ; Paul F. Herbert, Methods for fabricating polymer-based controlled release devices.
  43. Tracy Mark A. ; Herberger John D. ; Burke Paul A. ; Herbert Paul F., Methods for fabricating polymer-based controlled release devices.
  44. Burke Paul A., Microencapsulation and sustained release of oligonucleotides.
  45. Tice Thomas R. (Helena AL) Lewis Danny H. (Gardendale AL), Microencapsulation process.
  46. Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL), Microencapsulation process and products therefrom.
  47. Brown, Larry R.; Giannoukakis, Nick; Gillis, Kimberly A.; Trucco, Massimo, Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes.
  48. Levy, Robert J.; Labhasetwar, Vinod; Cohen, Hagit, Microspheres containing condensed polyanionic bioactive agents and methods for their production.
  49. Robert J. Levy ; Vinod Labhasetwar ; Hagit Cohen IL, Microspheres containing condensed polyanionic bioactive agents and methods for their production.
  50. Bernstein, Howard; Zhang, Yan; Khan, M. Amin; Tracy, Mark A., Modulated release from biocompatible polymers.
  51. Rittler Hermann L. (Corning NY), Nanocrystalline materials.
  52. Stinchcomb Dan T. ; Jarvis Thale ; McSwiggen James, Nucleic acid based inhibition of CD40.
  53. Bennett C. Frank ; Vickers Timothy A., Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.
  54. Bennett C. Frank ; Vickers Timothy A., Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.
  55. Krishnendu Roy ; Shau-Ku Huang ; Hugh Sampson ; Kam W. Leong, Oral delivery of nucleic acid vaccines by particulate complexes.
  56. Bot, Adrian I.; Tarara, Thomas E.; Weers, Jeffry G.; Kabalnov, Alexev; Schutt, Ernest G.; Dellamary, Luis A., Particulate delivery systems and methods of use.
  57. Boyes Robert N. (St. Albans AL GB2) Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL) Pledger Kenneth L. (Huntsville AL), Pharmaceutical formulations comprising microcapsules.
  58. Haurum, John S.; Drejer, Kirsten; Morch, Ulrik Gregers Winther, Polyclonal antibody composition for treating allergy.
  59. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  60. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  61. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  62. Herbert Paul F. (Wayland MA) Hazrati Azar M. (Maineville OH), Preparation of biodegradable microparticles containing a biologically active agent.
  63. Ramstack J. Michael (Lebanon OH) Herbert Paul F. (Wayland MA) Strobel Jan (Westchester OH) Atkins Thomas J. (Cincinnati OH), Preparation of biodegradable microparticles containing a biologically active agent.
  64. Lyons, Shawn L.; Ramstack, J. Michael; Wright, Steven G., Preparation of microparticles having a selected release profile.
  65. Mathiowitz Edith (Brookline MA) Langer Robert S. (Somerville MA), Preparation of multiwall polymeric microcapsules.
  66. Cha Younsik (Salt Lake City UT) Choi Young Kweon (Salt Lake City UT) Pai Chaul Min (Taejon KRX), Preparation of peptide containing biodegradable microspheres by melt process.
  67. Debenedetti Pablo G. ; Lim Gio-Bin,KRX ; Prud'Homme Robert K., Preparation of protein microparticles by supercritical fluid precipitation.
  68. Ruiz Jean-Marc (Trelaze FRX), Preparation process of sustained release compositions and the compositions thus obtained.
  69. Jonsson, Monica; Laakso, Timo; Reslow, Mats, Process for producing microparticles.
  70. Takechi Nobuyuki,JPX ; Ohtani Seiji,JPX ; Nagai Akihiro,JPX, Production of microspheres.
  71. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsule.
  72. Okada Hiroaki (Suita JPX) Ogawa Yasuaki (Ibaraki JPX) Yashiki Takatsuka (Takarazuka JPX), Prolonged release microcapsule and its production.
  73. Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Yashiki Takatsuka (Hyogo JPX), Prolonged release microcapsules.
  74. Okada Hiroaki (Suita JPX) Inoue Yayoi (Kyoto JPX) Ogawa Yasuaki (Otokuni JPX), Prolonged release microcapsules.
  75. Okada Hiroaki (Suita JPX) Inoue Yayoi (Kyoto JPX) Ogawa Yasuaki (Otokuni-gun JPX), Prolonged release microcapsules.
  76. Bruno, Maria; Tagliaferri, Jenna; Lawson, Luke; Logan, Mark J.; Mumper, Russ, Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods.
  77. Andya James ; Cleland Jeffrey L. ; Hsu Chung C. ; Lam Xanthe M. ; Overcashier David E. ; Shire Steven J. ; Yang Janet Yu-Feng ; Wu Sylvia Sau-Yan, Protein formulation.
  78. Liu, Jun; Shire, Steven J., Reduced-viscosity concentrated protein formulations.
  79. Roser Bruce J.,GBX ; Kampinga Jaap,NLX ; Colaco Camilo,GBX ; Blair Julian,GBX, Solid dose delivery vehicle and methods of making same.
  80. Felix Franks GB; Ross H. M. Hatley GB, Storage of materials.
  81. Franks, Felix; Hatley, Ross H. M., Storage of materials.
  82. Yamamoto Masaki (Osaka JPX) Takada Shigeyuki (Osaka JPX) Ogawa Yasuaki (Osaka JPX), Sustained release microcapsule.
  83. Park, Jin Kyu; Park, Mork Soon; Kim, Dong Seon; Lim, Il Ho; Jee, Ung Kil; Myung, Pyung Keun; Kim, San Beom; Jung, Goo Young, Sustained release microparticle and method for preparing the same.
  84. Terrence L. Scott ; Larry R. Brown ; Frank J. Riske ; Charles D. Blizzard ; Julia Rashba-Step, Sustained release microspheres.
  85. Takechi Nobuyuki,JPX ; Ohtani Seiji,JPX ; Nagai Akihiro,JPX, Sustained release microspheres and preparation thereof.
  86. Suzuki Takehiko (Osaka-fu JPX) Nishioka Yukiko (Toyonaka JPX) Matsukawa Yasuhisa (Osaka JPX) Matsumoto Akihiro (Hirakata JPX) Kobayashi Masao (Kyoto JPX), Sustained release multi-core microsphere preparation and method for producing the same.
  87. Gustafsson Nils-Ove,SEX ; Laakso Timo,SEX ; Fyhr Peter,SEX ; Jonsson Monica,SEX, Sustained release particles.
  88. Habener Joel F. ; Miller Christopher P., Transcription factor and uses therefor.
  89. Fogelberg Mark J. (Muncie IN), Transmission anti-clash and anti-rattle brake.
  90. Reid Robert H. (Kensington MD) Boedeker Edgar C. (Chevy Chase MD) van Hamont John E. (Shape MD BEX) Setterstrom Jean A. (Takoma Park MD), Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompa.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로